<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">27307042</PMID><DateCompleted><Year>2017</Year><Month>05</Month><Day>04</Day></DateCompleted><DateRevised><Year>2021</Year><Month>02</Month><Day>05</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1083-351X</ISSN><JournalIssue CitedMedium="Internet"><Volume>291</Volume><Issue>32</Issue><PubDate><Year>2016</Year><Month>Aug</Month><Day>05</Day></PubDate></JournalIssue><Title>The Journal of biological chemistry</Title><ISOAbbreviation>J Biol Chem</ISOAbbreviation></Journal><ArticleTitle>Gene Expression and Antiviral Activity of Interleukin-35 in Response to Influenza A Virus Infection.</ArticleTitle><Pagination><StartPage>16863</StartPage><EndPage>16876</EndPage><MedlinePgn>16863-76</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1074/jbc.M115.693101</ELocationID><Abstract><AbstractText>Interleukin-35 (IL-35) is a newly described member of the IL-12 family. It has been reported to inhibit inflammation and autoimmune inflammatory disease and can increase apoptotic sensitivity. Little is known about the role of IL-35 during viral infection. Herein, high levels of IL-35 were found in peripheral blood mononuclear cells and throat swabs from patients with seasonal influenza A virus (IAV) relative to healthy individuals. IAV infection of human lung epithelial and primary cells increased levels of IL-35 mRNA and protein. Further studies demonstrated that IAV-induced IL-35 transcription is regulated by NF-&#x3ba;B. IL-35 expression was significantly suppressed by selective inhibitors of cyclooxygenase-2 (COX-2) and inducible nitric-oxide synthase, indicating their involvement in IL-35 expression. Interestingly, IL-35 production may have suppressed IAV RNA replication and viral protein synthesis via induction of type I and III interferons (IFN), leading to activation of downstream IFN effectors, including double-stranded RNA-dependent protein kinase, 2',5'-oligoadenylate synthetase, and myxovirus resistance protein. IL-35 exhibited extensive antiviral activity against the hepatitis B virus, enterovirus 71, and vesicular stomatitis virus. Our results demonstrate that IL-35 is a novel IAV-inducible cytokine, and its production elicits antiviral activity.</AbstractText><CopyrightInformation>&#xa9; 2016 by The American Society for Biochemistry and Molecular Biology, Inc.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Li</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>From the The State Key Laboratory of Virology, College of Life Sciences, Wuhan University, Wuhan, Hubei 430072, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhu</LastName><ForeName>Shengli</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>From the The State Key Laboratory of Virology, College of Life Sciences, Wuhan University, Wuhan, Hubei 430072, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Xu</LastName><ForeName>Gang</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>From the The State Key Laboratory of Virology, College of Life Sciences, Wuhan University, Wuhan, Hubei 430072, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Feng</LastName><ForeName>Jian</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>From the The State Key Laboratory of Virology, College of Life Sciences, Wuhan University, Wuhan, Hubei 430072, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Han</LastName><ForeName>Tao</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>From the The State Key Laboratory of Virology, College of Life Sciences, Wuhan University, Wuhan, Hubei 430072, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhao</LastName><ForeName>Fanpeng</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>From the The State Key Laboratory of Virology, College of Life Sciences, Wuhan University, Wuhan, Hubei 430072, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>She</LastName><ForeName>Ying-Long</ForeName><Initials>YL</Initials><AffiliationInfo><Affiliation>From the The State Key Laboratory of Virology, College of Life Sciences, Wuhan University, Wuhan, Hubei 430072, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liu</LastName><ForeName>Shi</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>From the The State Key Laboratory of Virology, College of Life Sciences, Wuhan University, Wuhan, Hubei 430072, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ye</LastName><ForeName>Linbai</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>From the The State Key Laboratory of Virology, College of Life Sciences, Wuhan University, Wuhan, Hubei 430072, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhu</LastName><ForeName>Ying</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>From the The State Key Laboratory of Virology, College of Life Sciences, Wuhan University, Wuhan, Hubei 430072, China yingzhu@whu.edu.cn.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2016</Year><Month>06</Month><Day>15</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Biol Chem</MedlineTA><NlmUniqueID>2985121R</NlmUniqueID><ISSNLinking>0021-9258</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D007370">Interferon Type I</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D007378">Interleukins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D016328">NF-kappa B</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C532417">interleukin-35, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>82115-62-6</RegistryNumber><NameOfSubstance UI="D007371">Interferon-gamma</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 1.14.99.1</RegistryNumber><NameOfSubstance UI="D051546">Cyclooxygenase 2</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 1.14.99.1</RegistryNumber><NameOfSubstance UI="C496540">PTGS2 protein, human</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000072283" MajorTopicYN="N">A549 Cells</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D051546" MajorTopicYN="N">Cyclooxygenase 2</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005786" MajorTopicYN="N">Gene Expression Regulation</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006509" MajorTopicYN="N">Hepatitis B</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006515" MajorTopicYN="N">Hepatitis B virus</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007113" MajorTopicYN="Y">Immunity, Innate</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009980" MajorTopicYN="N">Influenza A virus</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007251" MajorTopicYN="N">Influenza, Human</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007370" MajorTopicYN="N">Interferon Type I</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007371" MajorTopicYN="N">Interferon-gamma</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007378" MajorTopicYN="N">Interleukins</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D019169" MajorTopicYN="N">Jurkat Cells</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016328" MajorTopicYN="N">NF-kappa B</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">NF-&#x3ba;B (NF-KB)</Keyword><Keyword MajorTopicYN="N">antiviral agent</Keyword><Keyword MajorTopicYN="N">host defense</Keyword><Keyword MajorTopicYN="N">host-pathogen interaction</Keyword><Keyword MajorTopicYN="N">influenza virus</Keyword><Keyword MajorTopicYN="N">innate immunity</Keyword><Keyword MajorTopicYN="N">interferon</Keyword><Keyword MajorTopicYN="N">interleukin</Keyword><Keyword MajorTopicYN="N">viral infection</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2015</Year><Month>9</Month><Day>22</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2016</Year><Month>6</Month><Day>17</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2016</Year><Month>6</Month><Day>17</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2017</Year><Month>5</Month><Day>5</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2017</Year><Month>8</Month><Day>5</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">27307042</ArticleId><ArticleId IdType="pmc">PMC4974397</ArticleId><ArticleId IdType="doi">10.1074/jbc.M115.693101</ArticleId><ArticleId IdType="pii">S0021-9258(20)35405-3</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Tripathi S., White M. R., and Hartshorn K. L. (2015) The amazing innate immune response to influenza A virus infection. Innate Immun. 21, 73&#x2013;98</Citation><ArticleIdList><ArticleId IdType="pubmed">24217220</ArticleId></ArticleIdList></Reference><Reference><Citation>Shaw M. W., Arden N. H., and Maassab H. F. (1992) New aspects of influenza viruses. Clin. Microbiol. Rev. 5, 74&#x2013;92</Citation><ArticleIdList><ArticleId IdType="pmc">PMC358224</ArticleId><ArticleId IdType="pubmed">1310439</ArticleId></ArticleIdList></Reference><Reference><Citation>Londrigan S. L., Tate M. D., Brooks A. G., and Reading P. C. (2012) Cell-surface receptors on macrophages and dendritic cells for attachment and entry of influenza virus. J. Leukoc. Biol. 92, 97&#x2013;106</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7166464</ArticleId><ArticleId IdType="pubmed">22124137</ArticleId></ArticleIdList></Reference><Reference><Citation>Mogensen T. H., and Paludan S. R. (2001) Molecular pathways in virus-induced cytokine production. Microbiol. Mol. Biol. Rev. 65, 131&#x2013;150</Citation><ArticleIdList><ArticleId IdType="pmc">PMC99022</ArticleId><ArticleId IdType="pubmed">11238989</ArticleId></ArticleIdList></Reference><Reference><Citation>Nakamura R., Maeda N., Shibata K., Yamada H., Kase T., and Yoshikai Y. (2010) Interleukin-15 is critical in the pathogenesis of influenza a virus-induced acute lung injury. J. Virol. 84, 5574&#x2013;5582</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2876592</ArticleId><ArticleId IdType="pubmed">20335267</ArticleId></ArticleIdList></Reference><Reference><Citation>Li W., Yang F., Liu Y., Gong R., Liu L., Feng Y., Hu P., Sun W., Hao Q., Kang L., Wu J., and Zhu Y. (2009) Negative feedback regulation of IL-32 production by iNOS activation in response to dsRNA or influenza virus infection. Eur. J. Immunol. 39, 1019&#x2013;1024</Citation><ArticleIdList><ArticleId IdType="pubmed">19291698</ArticleId></ArticleIdList></Reference><Reference><Citation>Li W., Sun W., Liu L., Yang F., Li Y., Chen Y., Fang J., Zhang W., Wu J., and Zhu Y. (2010) IL-32: a host proinflammatory factor against influenza viral replication is upregulated by aberrant epigenetic modifications during influenza A virus infection. J. Immunol. 185, 5056&#x2013;5065</Citation><ArticleIdList><ArticleId IdType="pubmed">20889550</ArticleId></ArticleIdList></Reference><Reference><Citation>Fukuyama S., and Kawaoka Y. (2011) The pathogenesis of influenza virus infections: the contributions of virus and host factors. Curr. Opin. Immunol. 23, 481&#x2013;486</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3163725</ArticleId><ArticleId IdType="pubmed">21840185</ArticleId></ArticleIdList></Reference><Reference><Citation>Collison L. W., and Vignali D. A. (2008) Interleukin-35: odd one out or part of the family? Immunol. Rev. 226, 248&#x2013;262</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2631363</ArticleId><ArticleId IdType="pubmed">19161429</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang B., Dai S., Dong Z., Sun Y., Song X., Guo C., Zhu F., Wang Q., and Zhang L. (2014) The modulation of endoplasmic reticulum stress by chemical chaperone upregulates immune negative cytokine IL-35 in apolipoprotein E-deficient mice. PloS One 9, e87787.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3907489</ArticleId><ArticleId IdType="pubmed">24498194</ArticleId></ArticleIdList></Reference><Reference><Citation>Niedbala W., Wei X. Q., Cai B., Hueber A. J., Leung B. P., McInnes I. B., and Liew F. Y. (2007) IL-35 is a novel cytokine with therapeutic effects against collagen-induced arthritis through the expansion of regulatory T cells and suppression of Th17 cells. Eur. J. Immunol. 37, 3021&#x2013;3029</Citation><ArticleIdList><ArticleId IdType="pubmed">17874423</ArticleId></ArticleIdList></Reference><Reference><Citation>Devergne O., Hummel M., Koeppen H., Le Beau M. M., Nathanson E. C., Kieff E., and Birkenbach M. (1996) A novel interleukin-12 p40-related protein induced by latent Epstein-Barr virus infection in B lymphocytes. J. Virol. 70, 1143&#x2013;1153</Citation><ArticleIdList><ArticleId IdType="pmc">PMC189923</ArticleId><ArticleId IdType="pubmed">8551575</ArticleId></ArticleIdList></Reference><Reference><Citation>Devergne O., Birkenbach M., and Kieff E. (1997) Epstein-Barr virus-induced gene 3 and the p35 subunit of interleukin 12 form a novel heterodimeric hematopoietin. Proc. Natl. Acad. Sci. U.S.A. 94, 12041&#x2013;12046</Citation><ArticleIdList><ArticleId IdType="pmc">PMC23696</ArticleId><ArticleId IdType="pubmed">9342359</ArticleId></ArticleIdList></Reference><Reference><Citation>Collison L. W., Delgoffe G. M., Guy C. S., Vignali K. M., Chaturvedi V., Fairweather D., Satoskar A. R., Garcia K. C., Hunter C. A., Drake C. G., Murray P. J., and Vignali D. A. (2012) The composition and signaling of the IL-35 receptor are unconventional. Nat. Immunol. 13, 290&#x2013;299</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3529151</ArticleId><ArticleId IdType="pubmed">22306691</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu J. Q., Liu Z., Zhang X., Shi Y., Talebian F., Carl J. W. Jr., Yu C., Shi F. D., Whitacre C. C., Trgovcich J., and Bai X. F. (2012) Increased Th17 and regulatory T cell responses in EBV-induced gene 3-deficient mice lead to marginally enhanced development of autoimmune encephalomyelitis. J. Immunol. 188, 3099&#x2013;3106</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3311737</ArticleId><ArticleId IdType="pubmed">22387555</ArticleId></ArticleIdList></Reference><Reference><Citation>Bettini M., Castellaw A. H., Lennon G. P., Burton A. R., and Vignali D. A. (2012) Prevention of autoimmune diabetes by ectopic pancreatic &#x3b2;-cell expression of interleukin-35. Diabetes 61, 1519&#x2013;1526</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3357277</ArticleId><ArticleId IdType="pubmed">22427377</ArticleId></ArticleIdList></Reference><Reference><Citation>Wirtz S., Billmeier U., Mchedlidze T., Blumberg R. S., and Neurath M. F. (2011) Interleukin-35 mediates mucosal immune responses that protect against T-cell-dependent colitis. Gastroenterology 141, 1875&#x2013;1886</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3624892</ArticleId><ArticleId IdType="pubmed">21820391</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang C. H., Loo E. X., Kuo I. C., Soh G. H., Goh D. L., Lee B. W., and Chua K. Y. (2011) Airway inflammation and IgE production induced by dust mite allergen-specific memory/effector Th2 cell line can be effectively attenuated by IL-35. J. Immunol. 187, 462&#x2013;471</Citation><ArticleIdList><ArticleId IdType="pubmed">21613618</ArticleId></ArticleIdList></Reference><Reference><Citation>Wong C. K., Leung T. F., Chu I. M., Dong J., Lam Y. Y., and Lam C. W. (2015) Aberrant expression of regulatory cytokine IL-35 and pattern recognition receptor NOD2 in patients with allergic asthma. Inflammation 38, 348&#x2013;360</Citation><ArticleIdList><ArticleId IdType="pubmed">25326182</ArticleId></ArticleIdList></Reference><Reference><Citation>Jafarzadeh A., Jamali M., Mahdavi R., Ebrahimi H. A., Hajghani H., Khosravimashizi A., Nemati M., Najafipour H., Sheikhi A., Mohammadi M. M., and Daneshvar H. (2015) Circulating levels of interleukin-35 in patients with multiple sclerosis: evaluation of the influences of FOXP3 gene polymorphism and treatment program. J. Mol. Neurosci. 55, 891&#x2013;897</Citation><ArticleIdList><ArticleId IdType="pubmed">25326790</ArticleId></ArticleIdList></Reference><Reference><Citation>Kalburgi N. B., Muley A., Shivaprasad B. M., and Koregol A. C. (2013) Expression profile of IL-35 mRNA in gingiva of chronic periodontitis and aggressive periodontitis patients: a semiquantitative RT-PCR study. Dis. Markers 35, 819&#x2013;823</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3860092</ArticleId><ArticleId IdType="pubmed">24376289</ArticleId></ArticleIdList></Reference><Reference><Citation>Zeng J. C., Zhang Z., Li T. Y., Liang Y. F., Wang H. M., Bao J. J., Zhang J. A., Wang W. D., Xiang W. Y., Kong B., Wang Z. Y., Wu B. H., Chen X. D., He L., Zhang S., Wang C. Y., and Xu J. F. (2013) Assessing the role of IL-35 in colorectal cancer progression and prognosis. Int. J. Clin. Exp. Pathol. 6, 1806&#x2013;1816</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3759487</ArticleId><ArticleId IdType="pubmed">24040445</ArticleId></ArticleIdList></Reference><Reference><Citation>Long J., Zhang X., Wen M., Kong Q., Lv Z., An Y., and Wei X. Q. (2013) IL-35 over-expression increases apoptosis sensitivity and suppresses cell growth in human cancer cells. Biochem. Biophys. Res. Commun. 430, 364&#x2013;369</Citation><ArticleIdList><ArticleId IdType="pubmed">23154182</ArticleId></ArticleIdList></Reference><Reference><Citation>Sakaguchi S., Sakaguchi N., Shimizu J., Yamazaki S., Sakihama T., Itoh M., Kuniyasu Y., Nomura T., Toda M., and Takahashi T. (2001) Immunologic tolerance maintained by CD25+ CD4+ regulatory T cells: their common role in controlling autoimmunity, tumor immunity, and transplantation tolerance. Immunol. Rev. 182, 18&#x2013;32</Citation><ArticleIdList><ArticleId IdType="pubmed">11722621</ArticleId></ArticleIdList></Reference><Reference><Citation>Shevach E. M., DiPaolo R. A., Andersson J., Zhao D. M., Stephens G. L., and Thornton A. M. (2006) The lifestyle of naturally occurring CD4+ CD25+ Foxp3+ regulatory T cells. Immunol. Rev. 212, 60&#x2013;73</Citation><ArticleIdList><ArticleId IdType="pubmed">16903906</ArticleId></ArticleIdList></Reference><Reference><Citation>Collison L. W., Chaturvedi V., Henderson A. L., Giacomin P. R., Guy C., Bankoti J., Finkelstein D., Forbes K., Workman C. J., Brown S. A., Rehg J. E., Jones M. L., Ni H. T., Artis D., Turk M. J., and Vignali D. A. (2010) IL-35-mediated induction of a potent regulatory T cell population. Nat. Immunol. 11, 1093&#x2013;1101</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3008395</ArticleId><ArticleId IdType="pubmed">20953201</ArticleId></ArticleIdList></Reference><Reference><Citation>Collison L. W., Workman C. J., Kuo T. T., Boyd K., Wang Y., Vignali K. M., Cross R., Sehy D., Blumberg R. S., and Vignali D. A. (2007) The inhibitory cytokine IL-35 contributes to regulatory T-cell function. Nature 450, 566&#x2013;569</Citation><ArticleIdList><ArticleId IdType="pubmed">18033300</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang J., Yang M., Htut T. M., Ouyang X., Hanidu A., Li X., Sellati R., Jiang H., Zhang S., Li H., Zhao J., Ting A. T., Mayer L., Unkeless J. C., Labadia M. E., Hodge M., Li J., and Xiong H. (2008) Epstein-Barr virus-induced gene 3 negatively regulates IL-17, IL-22 and ROR&#x3b3;t. Eur. J. Immunol. 38, 1204&#x2013;1214</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2989250</ArticleId><ArticleId IdType="pubmed">18412165</ArticleId></ArticleIdList></Reference><Reference><Citation>Xiang X. G., and Xie Q. (2015) IL-35: a potential therapeutic target for controlling hepatitis B virus infection. J. Dig. Dis. 16, 1&#x2013;6</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7162105</ArticleId><ArticleId IdType="pubmed">25476593</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu F., Tong F., He Y., and Liu H. (2011) Detectable expression of IL-35 in CD4+ T cells from peripheral blood of chronic hepatitis B patients. Clin. Immunol. 139, 1&#x2013;5</Citation><ArticleIdList><ArticleId IdType="pubmed">21285006</ArticleId></ArticleIdList></Reference><Reference><Citation>Shi Y. Y., Dai M. J., Wu G. P., Zhou P. P., Fang Y., and Yan X. B. (2015) Levels of interleukin-35 and its relationship with regulatory T-cells in chronic hepatitis B patients. Viral Immunol. 28, 93&#x2013;100</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4334469</ArticleId><ArticleId IdType="pubmed">25494369</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu L., Cao Z., Chen J., Li R., Cao Y., Zhu C., Wu K., Wu J., Liu F., and Zhu Y. (2012) Influenza A virus induces interleukin-27 through cyclooxygenase-2 and protein kinase A signaling. J. Biol. Chem. 287, 11899&#x2013;11910</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3320938</ArticleId><ArticleId IdType="pubmed">22343630</ArticleId></ArticleIdList></Reference><Reference><Citation>Paich H. A., Sheridan P. A., Handy J., Karlsson E. A., Schultz-Cherry S., Hudgens M. G., Noah T. L., Weir S. S., and Beck M. A. (2013) Overweight and obese adult humans have a defective cellular immune response to pandemic H1N1 influenza A virus. Obesity 21, 2377&#x2013;2386</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3695020</ArticleId><ArticleId IdType="pubmed">23512822</ArticleId></ArticleIdList></Reference><Reference><Citation>Park M. K., Ngo V., Kwon Y. M., Lee Y. T., Yoo S., Cho Y. H., Hong S. M., Hwang H. S., Ko E. J., Jung Y. J., Moon D. W., Jeong E. J., Kim M. C., Lee Y. N., Jang J. H., Oh J. S., Kim C. H., and Kang S. M. (2013) Lactobacillus plantarum DK119 as a probiotic confers protection against influenza virus by modulating innate immunity. PloS One 8, e75368.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3790790</ArticleId><ArticleId IdType="pubmed">24124485</ArticleId></ArticleIdList></Reference><Reference><Citation>Pirhonen J., Matikainen S., and Julkunen I. (2002) Regulation of virus-induced IL-12 and IL-23 expression in human macrophages. J. Immunol. 169, 5673&#x2013;5678</Citation><ArticleIdList><ArticleId IdType="pubmed">12421946</ArticleId></ArticleIdList></Reference><Reference><Citation>DiDonato J. A., Mercurio F., and Karin M. (2012) NF-&#x3ba;B and the link between inflammation and cancer. Immunol. Rev. 246, 379&#x2013;400</Citation><ArticleIdList><ArticleId IdType="pubmed">22435567</ArticleId></ArticleIdList></Reference><Reference><Citation>Razani B., Reichardt A. D., and Cheng G. (2011) Non-canonical NF-&#x3ba;B signaling activation and regulation: principles and perspectives. Immunol. Rev. 244, 44&#x2013;54</Citation><ArticleIdList><ArticleId IdType="pubmed">22017430</ArticleId></ArticleIdList></Reference><Reference><Citation>Poleganov M. A., Bachmann M., Pfeilschifter J., and M&#xfc;hl H. (2008) Genome-wide analysis displays marked induction of EBI3/IL-27B in IL-18-activated AML-derived KG1 cells: critical role of two &#x3ba;B binding sites in the human EBI3 promotor. Mol. Immunol. 45, 2869&#x2013;2880</Citation><ArticleIdList><ArticleId IdType="pubmed">18336908</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang Q., Chen X., Feng J., Cao Y., Song Y., Wang H., Zhu C., Liu S., and Zhu Y. (2013) Soluble interleukin-6 receptor-mediated innate immune response to DNA and RNA viruses. J. Virol. 87, 11244&#x2013;11254</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3807281</ArticleId><ArticleId IdType="pubmed">23946454</ArticleId></ArticleIdList></Reference><Reference><Citation>Yue X., Yang F., Yang Y., Mu Y., Sun W., Li W., Xu D., Wu J., and Zhu Y. (2011) Induction of cyclooxygenase-2 expression by hepatitis B virus depends on demethylation-associated recruitment of transcription factors to the promoter. Virol. J. 8, 118.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3066118</ArticleId><ArticleId IdType="pubmed">21401943</ArticleId></ArticleIdList></Reference><Reference><Citation>Mohammed N. A., Abd El-Aleem S. A., El-Hafiz H. A., and McMahon R. F. (2004) Distribution of constitutive (COX-1) and inducible (COX-2) cyclooxygenase in postviral human liver cirrhosis: a possible role for COX-2 in the pathogenesis of liver cirrhosis. J. Clin. Pathol. 57, 350&#x2013;354</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1770276</ArticleId><ArticleId IdType="pubmed">15047734</ArticleId></ArticleIdList></Reference><Reference><Citation>Li Y., Xie J., Xu X., Liu L., Wan Y., Liu Y., Zhu C., and Zhu Y. (2013) Inducible interleukin 32 (IL-32) exerts extensive antiviral function via selective stimulation of interferon &#x3bb;1 (IFN-&#x3bb;1). J. Biol. Chem. 288, 20927&#x2013;20941</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3774363</ArticleId><ArticleId IdType="pubmed">23729669</ArticleId></ArticleIdList></Reference><Reference><Citation>Ma X., Chow J. M., Gri G., Carra G., Gerosa F., Wolf S. F., Dzialo R., and Trinchieri G. (1996) The interleukin 12 p40 gene promoter is primed by interferon &#x3b3; in monocytic cells. J. Exp. Med. 183, 147&#x2013;157</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2192398</ArticleId><ArticleId IdType="pubmed">8551218</ArticleId></ArticleIdList></Reference><Reference><Citation>Kriegel M. A., Tretter T., Blank N., Schiller M., Gabler C., Winkler S., Kalden J. R., and Lorenz H. M. (2006) Interleukin-4 supports interleukin-12-induced proliferation and interferon-&#x3b3; secretion in human activated lymphoblasts and T helper type 1 cells. Immunology 119, 43&#x2013;53</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1782327</ArticleId><ArticleId IdType="pubmed">16762027</ArticleId></ArticleIdList></Reference><Reference><Citation>Parham C., Chirica M., Timans J., Vaisberg E., Travis M., Cheung J., Pflanz S., Zhang R., Singh K. P., Vega F., To W., Wagner J., O'Farrell A. M., McClanahan T., Zurawski S., Hannum C., et al. (2002) A receptor for the heterodimeric cytokine IL-23 is composed of IL-12R&#x3b2;1 and a novel cytokine receptor subunit, IL-23R. J. Immunol. 168, 5699&#x2013;5708</Citation><ArticleIdList><ArticleId IdType="pubmed">12023369</ArticleId></ArticleIdList></Reference><Reference><Citation>Hall A. O., Beiting D. P., Tato C., John B., Oldenhove G., Lombana C. G., Pritchard G. H., Silver J. S., Bouladoux N., Stumhofer J. S., Harris T. H., Grainger J., Wojno E. D., Wagage S., Roos D. S., et al. (2012) The cytokines interleukin 27 and interferon-&#x3b3; promote distinct Treg cell populations required to limit infection-induced pathology. Immunity 37, 511&#x2013;523</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3477519</ArticleId><ArticleId IdType="pubmed">22981537</ArticleId></ArticleIdList></Reference><Reference><Citation>Afkarian M., Sedy J. R., Yang J., Jacobson N. G., Cereb N., Yang S. Y., Murphy T. L., and Murphy K. M. (2002) T-bet is a STAT1-induced regulator of IL-12R expression in naive CD4+ T cells. Nat. Immunol. 3, 549&#x2013;557</Citation><ArticleIdList><ArticleId IdType="pubmed">12006974</ArticleId></ArticleIdList></Reference><Reference><Citation>Emeny J. M., and Morgan M. J. (1979) Regulation of the interferon system: evidence that Vero cells have a genetic defect in interferon production. J. Gen. Virol. 43, 247&#x2013;252</Citation><ArticleIdList><ArticleId IdType="pubmed">113494</ArticleId></ArticleIdList></Reference><Reference><Citation>Pauli E. K., Schmolke M., Wolff T., Viemann D., Roth J., Bode J. G., and Ludwig S. (2008) Influenza A virus inhibits type I IFN signaling via NF-&#x3ba;B-dependent induction of SOCS-3 expression. PLoS Pathog. 4, e1000196.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2572141</ArticleId><ArticleId IdType="pubmed">18989459</ArticleId></ArticleIdList></Reference><Reference><Citation>Prescott J., Hall P., Acuna-Retamar M., Ye C., Wathelet M. G., Ebihara H., Feldmann H., and Hjelle B. (2010) New World hantaviruses activate IFN&#x3bb; production in type I IFN-deficient vero E6 cells. PloS One 5, e11159.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2887373</ArticleId><ArticleId IdType="pubmed">20567522</ArticleId></ArticleIdList></Reference><Reference><Citation>Mukhtar M. M., Li S., Li W., Wan T., Mu Y., Wei W., Kang L., Rasool S. T., Xiao Y., Zhu Y., and Wu J. (2009) Single-chain intracellular antibodies inhibit influenza virus replication by disrupting interaction of proteins involved in viral replication and transcription. Int. J. Biochem. Cell Biol. 41, 554&#x2013;560</Citation><ArticleIdList><ArticleId IdType="pubmed">18687409</ArticleId></ArticleIdList></Reference><Reference><Citation>Short K. R., Veldhuis Kroeze E. J., Reperant L. A., Richard M., and Kuiken T. (2014) Influenza virus and endothelial cells: a species specific relationship. Front. Microbiol. 5, 653.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4251441</ArticleId><ArticleId IdType="pubmed">25520707</ArticleId></ArticleIdList></Reference><Reference><Citation>Netea M. G., Azam T., Lewis E. C., Joosten L. A., Wang M., Langenberg D., Meng X., Chan E. D., Yoon D. Y., Ottenhoff T., Kim S. H., and Dinarello C. A. (2006) Mycobacterium tuberculosis induces interleukin-32 production through a caspase- 1/IL-18/interferon-&#x3b3;-dependent mechanism. PLoS Med. 3, e277.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1539091</ArticleId><ArticleId IdType="pubmed">16903774</ArticleId></ArticleIdList></Reference><Reference><Citation>Ronni T., Sareneva T., Pirhonen J., and Julkunen I. (1995) Activation of IFN-&#x3b1;, IFN-&#x3b3;, MxA, and IFN regulatory factor 1 genes in influenza A virus-infected human peripheral blood mononuclear cells. J. Immunol. 154, 2764&#x2013;2774</Citation><ArticleIdList><ArticleId IdType="pubmed">7876547</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou Y., Zhang H., and Li Y. (2015) IL-35 expression in peripheral blood CD4(+) T cells from chronic hepatitis B virus-infected patients directly correlates with virus load. Cytokine 73, 169&#x2013;175</Citation><ArticleIdList><ArticleId IdType="pubmed">25752977</ArticleId></ArticleIdList></Reference><Reference><Citation>Li X., Tian L., Dong Y., Zhu Q., Wang Y., Han W., Liu X., Ni Q., Chen Y., and Li L. (2015) IL-35 inhibits HBV antigen-specific IFN-&#x3b3;-producing CTLs in vitro. Clin. Sci. 129, 395&#x2013;404</Citation><ArticleIdList><ArticleId IdType="pubmed">25869609</ArticleId></ArticleIdList></Reference><Reference><Citation>Li Q., and Verma I. M. (2002) NF-&#x3ba;B regulation in the immune system. Nat. Rev. Immunol. 2, 725&#x2013;734</Citation><ArticleIdList><ArticleId IdType="pubmed">12360211</ArticleId></ArticleIdList></Reference><Reference><Citation>Mercurio F., Zhu H., Murray B. W., Shevchenko A., Bennett B. L., Li J., Young D. B., Barbosa M., Mann M., Manning A., and Rao A. (1997) IKK-1 and IKK-2: cytokine-activated I&#x3ba;B kinases essential for NF-&#x3ba;B activation. Science 278, 860&#x2013;866</Citation><ArticleIdList><ArticleId IdType="pubmed">9346484</ArticleId></ArticleIdList></Reference><Reference><Citation>Zandi E., Rothwarf D. M., Delhase M., Hayakawa M., and Karin M. (1997) The I&#x3ba;B kinase complex (IKK) contains two kinase subunits, IKK&#x3b1; and IKK&#x3b2;, necessary for I&#x3ba;B phosphorylation and NF-&#x3ba;B activation. Cell 91, 243&#x2013;252</Citation><ArticleIdList><ArticleId IdType="pubmed">9346241</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee S. M., Cheung C. Y., Nicholls J. M., Hui K. P., Leung C. Y., Uiprasertkul M., Tipoe G. L., Lau Y. L., Poon L. L., Ip N. Y., Guan Y., and Peiris J. S. (2008) Hyperinduction of cyclooxygenase-2-mediated proinflammatory cascade: a mechanism for the pathogenesis of avian influenza H5N1 infection. J. Infect. Dis. 198, 525&#x2013;535</Citation><ArticleIdList><ArticleId IdType="pubmed">18613795</ArticleId></ArticleIdList></Reference><Reference><Citation>Li W., Liu Y., Mukhtar M. M., Gong R., Pan Y., Rasool S. T., Gao Y., Kang L., Hao Q., Peng G., Chen Y., Chen X., Wu J., and Zhu Y. (2008) Activation of interleukin-32 pro-inflammatory pathway in response to influenza A virus infection. PloS One 3, e1985.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2288676</ArticleId><ArticleId IdType="pubmed">18414668</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu L., Li R., Pan Y., Chen J., Li Y., Wu J., and Zhu Y. (2011) High-throughput screen of protein expression levels induced by cyclooxygenase-2 during influenza a virus infection. Clin. Chim. Acta 412, 1081&#x2013;1085</Citation><ArticleIdList><ArticleId IdType="pubmed">21354125</ArticleId></ArticleIdList></Reference><Reference><Citation>Imanishi N., Andoh T., Sakai S., Satoh M., Katada Y., Ueda K., Terasawa K., and Ochiai H. (2005) Induction of inducible nitric oxide (NO) synthase mRNA and NO production in macrophages infected with influenza A/PR/8 virus and stimulated with its ether-split product. Microbiol. Immunol. 49, 41&#x2013;48</Citation><ArticleIdList><ArticleId IdType="pubmed">15665452</ArticleId></ArticleIdList></Reference><Reference><Citation>Rasool S. T., Tang H., Wu J., Li W., Mukhtar M. M., Zhang J., Mu Y., Xing H. X., Wu J., and Zhu Y. (2008) Increased level of IL-32 during human immunodeficiency virus infection suppresses HIV replication. Immunol. Lett. 117, 161&#x2013;167</Citation><ArticleIdList><ArticleId IdType="pubmed">18329725</ArticleId></ArticleIdList></Reference><Reference><Citation>Barnes B., Lubyova B., and Pitha P. M. (2002) On the role of IRF in host defense. J. Interferon Cytokine Res. 22, 59&#x2013;71</Citation><ArticleIdList><ArticleId IdType="pubmed">11846976</ArticleId></ArticleIdList></Reference><Reference><Citation>Robek M. D., Boyd B. S., and Chisari F. V. (2005) &#x3bb; interferon inhibits hepatitis B and C virus replication. J. Virol. 79, 3851&#x2013;3854</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1075734</ArticleId><ArticleId IdType="pubmed">15731279</ArticleId></ArticleIdList></Reference><Reference><Citation>Choi H. J., Dinarello C. A., and Shapiro L. (2001) Interleukin-18 inhibits human immunodeficiency virus type 1 production in peripheral blood mononuclear cells. J. Infect. Dis. 184, 560&#x2013;568</Citation><ArticleIdList><ArticleId IdType="pubmed">11494162</ArticleId></ArticleIdList></Reference><Reference><Citation>Zou F., Liu Y., Liu L., Wu K., Wei W., Zhu Y., and Wu J. (2007) Retinoic acid activates human inducible nitric-oxide synthase gene through binding of RAR&#x3b1;/RXR&#x3b1; heterodimer to a novel retinoic acid response element in the promoter. Biochem. Biophys. Res. Commun. 355, 494&#x2013;500</Citation><ArticleIdList><ArticleId IdType="pubmed">17306764</ArticleId></ArticleIdList></Reference><Reference><Citation>Pan Y., Wei W., Kang L., Wang Z., Fang J., Zhu Y., and Wu J. (2007) NS5A protein of HCV enhances HBV replication and resistance to interferon response. Biochem. Biophys. Res. Commun. 359, 70&#x2013;75</Citation><ArticleIdList><ArticleId IdType="pubmed">17532300</ArticleId></ArticleIdList></Reference><Reference><Citation>Yan X., Hao Q., Mu Y., Timani K. A., Ye L., Zhu Y., and Wu J. (2006) Nucleocapsid protein of SARS-CoV activates the expression of cyclooxygenase-2 by binding directly to regulatory elements for nuclear factor-&#x3ba; B and CCAAT/enhancer binding protein. Int. J. Biochem. Cell Biol. 38, 1417&#x2013;1428</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7108415</ArticleId><ArticleId IdType="pubmed">16546436</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>